A Staged Translational Framework for Evaluating Oral Glutamatergic and Senescence-Modulating Strategies in Treatment-Resistant Depression
Ngo Cheung · 2026
Read A Staged Translational Framework for Evaluating Oral Glutamatergic and Senescence-Modulating Strategies in Treatment-Resistant Depression by Ngo Cheung (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13526230.txt.
Description
Ngo Cheung, writing alone in 2026, lays out a staged plan for testing new drug combinations against depression that resists standard care. The paper is a framework and hypothesis piece, with no new patient or lab data. Its core idea pairs a fast-acting glutamate route, built on dextromethorphan with two partner drugs, against slower supports aimed at cell aging and energy.
The plan starts with measuring how the body handles the core mix, then checks safety and target effects before any efficacy trial. Aging-directed drugs, such as dasatinib with quercetin, are held for a late, closely watched stage only. Add-on nutrients are classed as exploratory. Cheung stresses that none of the combinations has a clinical role yet and none should be used outside formal research. The sequence is meant to sort real promise from hope in a hard-to-treat group.
Catalog record
| CREATOR | Ngo Cheung |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |